Wearable features that provide medical diagnoses require FDA clearance, whereas non-diagnostic health monitoring is classified by the FDA as general wellness

Overview Debates Related claims Topics

The United States FDA issued a warning letter to WHOOP regarding WHOOP's Blood Pressure Insights feature

WHOOP holds FDA 510(k) clearance for its on-device electrocardiogram feature

Purdue Pharma manufactured and marketed the prescription opioid analgesic OxyContin

Under the Donald Trump presidential administration, the United States Food and Drug Administration approved the generic version of the abortion pill mifepristone

Texas blue laws prohibiting the Sunday sale of 42 specific consumer goods, including electronics, clothing, and kitchen utensils, were repealed in 1985

Texas law prohibits motor vehicle dealerships from selling vehicles on both Saturday and Sunday of the same weekend

Texas law permits restaurants to serve alcoholic beverages starting at 10:00 a.m. on Sundays if the alcohol is accompanied by food service

Package stores selling distilled spirits in Texas are legally required to remain closed on Sundays

Approximately 90% of individuals who stop taking injectable GLP-1 receptor agonists regain their lost weight within 15 months

Injectable synthetic GLP-1 drugs suppress endogenous natural production of appetite-suppressing hormones

Semaglutide administration reduces voluntary caloric intake by approximately 24%

Pharmaceutical GLP-1 receptor agonists elevate circulating GLP-1 activity to approximately 3,000% of baseline levels

Mark Cuban Cost Plus Drug Company developed modular drug manufacturing units housed within tractor-trailer-sized pods

Florida pain management clinics historically operated affiliated on-site pharmacies that exclusively dispensed OxyContin without real-time prescription tracking databases

Cost Plus Marketplace sells sterile injectables to clinics and hospitals at a transparent markup of 10% or 12% above cost

Anthropic acquired Mithril Medicine, a one-person biotechnology company developing therapies for two rare forms of muscular dystrophy

Merck voluntarily withdrew the anti-inflammatory medication Vioxx from the market after clinical data linked Vioxx to tens of thousands of fatal strokes

Mithril Medicine advanced an antibody treatment candidate for muscular dystrophy from initial concept to proof of principle in mice within 18 months

Anthropic published an outline detailing its strategy to integrate artificial intelligence across every stage of the drug discovery process

Filing an Abbreviated New Drug Application with the FDA costs approximately $365,000 plus additional administrative fees